Skip to main content

Table 2 Kinetic parameters estimated using the 7-parameter and 5-parameter models (LEV: n = 4, BRV: n = 5)

From: Drug characteristics derived from kinetic modeling: combined 11C-UCB-J human PET imaging with levetiracetam and brivaracetam occupancy of SV2A

Model

Region

AED

11C-UCB-J

AED

K1D(µL/cm3/min)

koffD(1/min)

VT (mL/cm3)

fND

K1 (mL/cm3/min)

koff(1/min)

Displacement

Post-dose

7-parameter

Putamen

LEV

6.2 (45%)

4.2 (47%)

22.2 (5%)

0.075 (13%)

0.46 (5%)

0.49 (8%)

5.5 (31%)

Frontal cortex

LEV

5.3 (42%)

4.9 (71%)

18.9 (5%)

0.087 (13%)

0.43 (5%)

0.44 (7%)

4.6 (39%)

Cerebellum

LEV

4.8 (81%)

8.9 (679%)

13.8 (5%)

0.093 (14%)

0.41 (5%)

0.38 (6%)

3.4 (32%)

Putamen

BRV

75.3 (86%)

9.2 (271%)

21.5 (6%)

0.087 (31%)

0.46 (6%)

0.45 (12%)

8.5 (40%)

Frontal cortex

BRV

321.6 (99%)

9.0 (133%)

18.6 (6%)

0.098 (27%)

0.44 (7%)

0.41 (20%)

5.4 (37%)

Cerebellum

BRV

58.9 (91%)

10.1 (923%)

13.9 (6%)

0.096 (23%)

0.37 (6%)

0.35 (15%)

8.8 (34%)

5-parameter

Putamen

LEV

5.2 (42%)

 

21.6 (4%)

0.076 (11%)

0.47 (3%)

0.49 (5%)

 

Frontal cortex

LEV

5.1 (41%)

 

18.7 (4%)

0.088 (11%)

0.43 (3%)

0.43 (5%)

 

Cerebellum

LEV

4.0 (59%)

 

13.7 (4%)

0.099 (11%)

0.37 (4%)

0.36 (6%)

 

Putamen

BRV

88.3 (46%)

 

21.5 (5%)

0.089 (27%)

0.46 (4%)

0.46 (10%)

 

Frontal cortex

BRV

72.9 (49%)

 

18.3 (5%)

0.105 (26%)

0.44 (4%)

0.42 (10%)

 

Cerebellum

BRV

43.9 (57%)

 

13.5 (5%)

0.094 (21%)

0.37 (4%)

0.35 (11%)

 
  1. Data are median parameter estimates (median percent standard error) for AEDs and mean parameter estimates (mean percent standard error) for the 11C-UCB-J